(Q44387971)

2 December 2017

title

Molecular indicators of non-sentinel node status in breast cancer determined in preoperative biopsies by multiplexed sandwich immunoassays (English)

1 reference

2 December 2017

Georg Sauer

1

1 reference

2 December 2017

Nicole Schneiderhan-Marra

2

1 reference

2 December 2017

Rainer Muche

3

1 reference

2 December 2017

Karin Koretz

4

1 reference

2 December 2017

Cornelia Kazmaier

5

1 reference

2 December 2017

Rolf Kreienberg

6

1 reference

2 December 2017

Thomas Joos

7

1 reference

2 December 2017

Helmut Deissler

8

1 reference

2 December 2017

publication date

24 April 2011

1 reference

Journal of Cancer Research and Clinical Oncology

2 December 2017

published in

1 reference

2 December 2017

volume

137

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1175-1184

1 reference

Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Completion of axillary dissection for a positive sentinel node: necessary or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Is axillary dissection needed in node-positive breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Can axillary dissection be avoided in patients with sentinel lymph node metastasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Multiplexed immunoassays for the analysis of breast cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Study of matrix metalloproteinases and their inhibitors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-0982-4

Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node

21 January 2018

1 reference

12 December 2020

Prediction of nodal involvement in breast cancer based on multiparametric protein analyses from preoperative core needle biopsies of the primary lesion

1 reference

12 December 2020

A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis

1 reference

12 December 2020

Sentinel lymphadenectomy in breast cancer

1 reference

12 December 2020

Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation

1 reference

12 December 2020

A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive

1 reference

12 December 2020

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

1 reference

12 December 2020

An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement

1 reference

12 December 2020

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study

1 reference

12 December 2020

10.1007/S00432-011-0982-4

Identifiers

DOI

1 reference

2 December 2017

1 reference